Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T6781 |
Benzenesulfonamide
Benzenesulphonamide,苯磺酰胺,Phenyl sulfonamide,Benzosulfonamide |
Carbonic Anhydrase | Metabolism |
Benzenesulfonamide (Benzosulfonamide) 是碳酸酐酶的抑制剂。 | |||
T2134 |
Dorzolamide hydrochloride
MK507 hydrochloride,L671152 hydrochloride,MK-507 (L-671152) HCl,盐酸多佐胺,Dorzolamide HCl |
Carbonic Anhydrase | Metabolism |
Dorzolamide hydrochloride (MK507 hydrochloride) 是一种碳酸酐酶carbonic anhydrase II 抑制剂,能够抑制红细胞CA-II(IC50:0.18 nM) 和CA-I(IC50:600 nM) 。 | |||
T0782 |
Benzthiazide
Aquatag,苄噻嗪,Lemazide,Dihydrex |
Carbonic Anhydrase | Metabolism |
Benzthiazide (Lemazide) 是长效利尿剂及抗高血压剂。它也是碳酸酐酶 9 的抑制剂,他对 CA9,CA2 和 CA1 的 Ki 分别为 8.0,8.8 和 10 nM。它对肿瘤细胞增殖具有抑制作用。 | |||
T61829 | Carbonic anhydrase inhibitor 4 | ||
Carbonic anhydrase inhibitor 4 is a photoprobe that inhibits the activity of carbonic anhydrase. It specifically targets human carbonic anhydrases, including hCA I-XIV, with K i values ranging from 640-1166 nM [1]. | |||
T35713 | N-desethyl Brinzolamide (oxalate) | ||
N-desethyl Brinzolamide is an active metabolite of the carbonic anhydrase (CA) inhibitor brinzolamide .1It inhibits CAII and CAIV activities (IC50s = 1.28 and 128 nM, respectively). 1.Kim, C.-Y., Whittington, D.A., Chang, J.S., et al.Structural aspects of isozyme selectivity in the binding of inhibitors to carbonic anhydrases II and IVJ. Med. Chem.45(4)888-893(2002) | |||
T79753 |
hCAIX/XII-IN-8
|
Carbonic Anhydrase | Metabolism |
hCAIX/XII-IN-8(compound 3g)是一种对人类(碳酸酐酶)CA IX和XII高效的抑制剂,Ki值分别为8.5和6.7 nM。该化合物对与肿瘤相关的膜结合异构体hCA IX和XII表现出显著的抑制作用,且相对于胞内异构体hCA I和II具有较高的选择性。 | |||
T79591 |
hCA/VEGFR-2-IN-4
|
VEGFR | Angiogenesis; Tyrosine Kinase/Adaptors |
hCA/VEGFR-2-IN-4 (化合物15b) 是一种具有癌症治疗潜力的吲哚酮基苯磺酰胺类双重抑制剂,旨在抑制与癌症相关的hCA IX/XII 和VEGFR-2。该化合物对VEGFR-2具有较强的抑制能力(IC50=0.811 μM),并对hCAs展现高亲和性,其Ki值分别为hCA XII的3.8 nM,hCA IX的6.2 nM,hCA II的19.8 nM,以及hCA I的35.5 nM。此外,hCA/VEGFR-2-IN-4 对于VEGFR-2过表达的乳腺癌细胞有抗增殖作用。 |